Diabetes Research: Open Access
Article Type: Commentary
Diab Res Open Access. 2021 Jun 10;3(2):30-32
1Medical Research/Tokushima University, Tokushima, Japan
2Japan Low Carbohydrate Diet Promotion Association (JLCDPA), Kyoto, Japan
Corresponding Author: Hiroshi BANDO, MD, PhD, FACP ORCID iD
Address: Tokushima University /Medical Research, Nakashowa 1-61, Tokushima 770-0943, Japan.
Received date: 20 April 2021; Accepted date: 02 June 2021; Published date: 10 June 2021
Citation: Bando H. Beneficial and Therapeutic Potential of Ketone Bodies (KB) in Clinical Practice. Diab Res Open Access. 2021 Jun 10;3(2):30-32.
Copyright © 2021 Bando H. This is an open-access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Keywords: Ketone Bodies, American College of Cardiology, Low Carbohydrate Diet, Cardiovascular, β-Hydroxybutyrate
Abbreviations: KB: Ketone Bodies; ACC: American College of Cardiology; LCD: Low Carbohydrate Diet; CV: Cardiovascular; βHB: β-hydroxybutyrate
Various discussion exists concerning ketone bodies (KB) for beneficial effects. In 2021, the American College of Cardiology (ACC) has presented the therapeutic potential of KB for cardiovascular (CV) disease. KB cover 10-15% of cardiac production of ATP, elevation of cardiac energetics, and reduction of cardiac remodeling, inflammation, and oxidative stress.